MyFinsight
Home
Blog
About
Contact
sabs: the balance sheet
Download
Download image
Total property, plant
and equipment,...
$29,935,070
Prepaid expenses and
other current assets
$1,836,160
Accrued interest
receivable
$559,954
Short-term investments
$81,455,925
Cash and cash
equivalents
$29,424,708
Property, plant and
equipment, net
$13,114,339
Financing lease
right-of-use assets
$3,517,718
Operating lease
right-of-use assets
$2,806,904
Long-term investments
$50,608,587
Long-term prepaid assets
$124,073
Total current assets
$113,276,747
Less accumulated
depreciation and...
$16,820,731
Total assets
$183,448,368
Total liabilities and
stockholders' equity
$183,448,368
Total stockholders'
equity
$165,074,349
Total liabilities
$18,374,019
Accumulated deficit
-$94,034,424
Treasury stock, at cost
54,665 shares held at...
$5,521,246
Accumulated other
comprehensive income (loss)
$71,223
Additional paid-in capital
$264,553,973
Warrant liabilities
$2,381,677
Finance lease
liabilities, noncurrent
$3,161,562
Operating lease
liabilities, noncurrent
$2,037,461
Total current
liabilities
$10,793,319
Common stock 0.0001 par
value 800,000,000...
$4,756
Preferred stock-Series
BPreferred Stock
$64
Preferred stock-Series
APreferred Stock
$3
Finance lease
liabilities, current portion
$151,033
Operating lease
liabilities, current portion
$837,286
Accrued expenses and
other current...
$6,850,015
Accounts payable
$2,954,985
Back
Back
Balance Sheet
source: myfinsight.com
SAB Biotherapeutics, Inc. (SABS)
SAB Biotherapeutics, Inc. (SABS)